Your browser doesn't support javascript.
loading
Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials.
Takahashi, Toshinari; Beppu, Takanobu; Hidaka, Yuji; Hosoya, Tatsuo.
Affiliation
  • Takahashi T; Medical Affairs Department, Mochida Pharmaceutical Co., Ltd, Tokyo, Japan.
  • Beppu T; Medical Affairs Department, Fuji Yakuhin Co., Ltd, Tokyo, Japan.
  • Hidaka Y; Akasaka Central Clinic, Tokyo, Japan.
  • Hosoya T; Emeritus professor, Jikei University School of Medicine, Tokyo, Japan.
Clin Exp Hypertens ; 43(8): 730-741, 2021 Nov 17.
Article in En | MEDLINE | ID: mdl-34425059
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Hyperuricemia / Gout / Hypertension Type of study: Guideline / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Clin Exp Hypertens Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Hyperuricemia / Gout / Hypertension Type of study: Guideline / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Clin Exp Hypertens Year: 2021 Document type: Article Affiliation country: